Starpharma Holdings Limited - Sales Analysis Snapshot

Business Description
This Report provides a comprehensive Sales & Margin summary analysis for Starpharma Holdings Limited Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.

Starpharma Holdings Limited. The Group's principal activity is discovering, developing and commercialising dendrimers for pharmaceutical and other life science and industrial applications. The Group's activities are directed towards developing precisely defined nano-scale materials, with a particular focus on developing its topical vaginal microbicide VivaGel for preventing genital herpes and HIV, and applying dendrimers to drug delivery and other life science applications. Other activity includes exploring dendrimer opportunities in materials science with applications in areas such as adhesives, lubricants and water remediation. Operations are carried out in Australia and United States.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report